Peripheral Blood
Melanoma peptide cocktail generates T cells against malignant melanoma
Published in Vaccine Weekly, July 28th, 2004
According to a study from Japan, "Many human leukocyte antigen (HLA)-class 1 (mainly A*0201)-restricted peptide-specific cytotoxic T cells (CTLs) have been derived from peripheral blood lymphocytes (PBLs) of melanoma patients. However; few studies regarding HLA-A*2402-restricted melanoma-associated peptides have been performed, because HL4-A24 is not a common allele in Caucasians. In this study, we investigated the specific CTL-inducing activity of 5 HLA-A*2402-restricted peptides derived from gp100, tyrosinase, MAGE1, MAGE2, and MAGE3."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-07-28)
More Articles from Vaccine Weekly
- Cancer Vaccine
Potent vaccine-induced anti-tumor T cell response characterized - DNA Vaccine
Heat-shock protein as dendritic cell target enhances vaccine potency - DNA Vaccine
Important factors for improving efficacy of DNA vaccines described - Human Papillomavirus Vaccine
Presentation system improves cellular immunity against papillomavirus - Virology Vaccine
Dendritic cell vaccine induces antiviral immunity - Adolescent Health
Adolescents and immunization: Tips for the primary care provider - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
